Predictors of Hematologic Malignancy Relapse in Patients with Advanced Chronic Graft-versus-Host Disease

Malignancy relapse remains a major barrier to treatment success in patients after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Chronic graft-versus-host disease (cGVHD) markedly reduces hematologic malignancy relapse risk, but relapses still occur in these patients. Patients (n=27...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruben, Claire L., Pirsl, Filip, Steinberg, Seth M., Holtzman, Noa G., Parsons-Wandell, Laura, Baruffaldi, Judy, Curtis, Lauren M., Mitchell, Sandra A., Kerep, Ana Zelic, Cowen, Edward W., Berger, Ann, Joe, Galen O., Datiles, Manuel B., Mays, Jacqueline W., Pavletic, Steven Z.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555869/
https://www.ncbi.nlm.nih.gov/pubmed/33526918
http://dx.doi.org/10.1038/s41409-021-01211-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555869/
https://www.ncbi.nlm.nih.gov/pubmed/33526918
http://dx.doi.org/10.1038/s41409-021-01211-2

Ejemplares similares